CompoAtlas

Ortho Ashwagnadha Plus

Food supplement declared in France, declaration No 2016-6-595, decision dated 17 June 2016

Ortho Ashwagnadha Plus (Orthonat nutrition) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Orthonat nutrition
Food business operator placing the product on the market
Laboratoires Vitanutrinat
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule
Not recommended for (according to the manufacturer)
Sous traitement pour la thyroïde

Declaration 274492, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacineExtrait sec aqueux600 mg
Cucumis melo L.FruitExtrait sec aqueux10 mg

Other active ingredients

NamePer day
Superoxyde dismutasenot declared

Additives

E140, Hydroxypropyl Méthyl Cellulose, E551

Other ingredients

amidon de maïs, amidon

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Orthonat nutrition

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line